Literature DB >> 31072769

The Impact of Cardiac Rehabilitation and Secondary Prevention Programs on 12-Month Clinical Outcomes: A Linked Data Analysis.

Carolyn M Astley1, Derek P Chew2, Wendy Keech3, Stephen Nicholls4, John Beltrame5, Matthew Horsfall6, Rosanna Tavella7, Rosy Tirimacco8, Robyn A Clark9.   

Abstract

BACKGROUND: Guidelines recommend referral to cardiac rehabilitation (CR) for cardiac event prevention and risk factor management, but poor attendance persists. Following the development of standardised data and uniform capture, CR services have contributed to three audits in South Australia, Australia. We aimed to determine if CR attendance impacts on cardiovascular readmission, morbidity and mortality.
METHODS: In a retrospective cohort study, CR databases were linked to hospital administrative datasets to compare the characteristics and outcomes of CR patients between 2013 and 2015. Inverse probability weighting methods were used to measure associations between CR attendance versus non-attendance and cardiovascular readmission and the composite of death, new/re-myocardial infarction, atrial fibrillation, heart failure and stroke within 12-months.
RESULTS: Of 49,909 eligible separations, 15,089/49,909 (30.2%) were referred to CR with an attendance rate of 4,286/15,089 (28.4%). Referred/declined patients were older (median: 67.3 vs 65.3 years, p < 0.001), more likely to be female (32.3% vs 26.5%, p < 0.001) with more heart failure (17.1% vs 10.9%, p < 0.001) and arrhythmia (6.1% vs 2.1%, p < 0.001) admissions and higher socio-economic disadvantage (median Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD): 950.1 vs 960.4, p < 0.001). Referred/attended patients had lower cardiovascular readmission, (referred/attended vs not referred: 15.6% vs 22.7% and referred/attended vs referred/declined: 15.6% vs 29.6%, p < 0.001). After clinical and social factors adjustment there was no difference in composite outcomes, but attendance was associated with reduced cardiovascular readmission (HR:0.68, 95% IQR: 0.58-0.81, p = 0.001).
CONCLUSIONS: Audit can measure service effectiveness, identifying areas for improvement. This study highlights patient eligibility, system and program considerations for future CR services.
Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.

Entities:  

Keywords:  Cardiovascular rehabilitation; Clinical audit; Clinical effectiveness; Data linkage analysis; Outcomes research; Secondary prevention

Mesh:

Year:  2019        PMID: 31072769     DOI: 10.1016/j.hlc.2019.03.015

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

Review 1.  Historical Context of Cardiac Rehabilitation: Learning From the Past to Move to the Future.

Authors:  Julie Redfern; Robyn Gallagher; Adrienne O'Neil; Sherry L Grace; Adrian Bauman; Garry Jennings; David Brieger; Tom Briffa
Journal:  Front Cardiovasc Med       Date:  2022-04-27

2.  Quality of life following cardiac rehabilitation in cardiac surgery patients.

Authors:  Ernest Christian Lourens; Robert Ashley Baker; Bronwyn M Krieg
Journal:  J Cardiothorac Surg       Date:  2022-05-31       Impact factor: 1.522

3.  Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and Readmission.

Authors:  Jason H Wasfy; Michael K Hidrue; Jacqueline Ngo; Varsha K Tanguturi; Elizabeth T Cafiero-Fonseca; Ryan W Thompson; Natalie Johnson; Susan T McDermott; Jagmeet P Singh; Marcela G Del Carmen; Timothy G Ferris
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-05-12

4.  Cardiac rehabilitation services: A global perspective on performance and barriers.

Authors:  J M L Hendriks; C Gallagher; C Astley; D Linz; R Gallagher
Journal:  Int J Cardiol Heart Vasc       Date:  2019-08-15

5.  Does tai chi improve psychological well-being and quality of life in patients with cardiovascular disease and/or cardiovascular risk factors? A systematic review.

Authors:  Guoyan Yang; Wenyuan Li; Nerida Klupp; Huijuan Cao; Jianping Liu; Alan Bensoussan; Hosen Kiat; Diana Karamacoska; Dennis Chang
Journal:  BMC Complement Med Ther       Date:  2022-01-04

6.  Assessing the quality of cardiac rehabilitation programs by measuring adherence to the Australian quality indicators.

Authors:  C M Astley; A Beleigoli; R Tavella; J Hendriks; C Gallagher; R Tirimacco; G Wilson; T Barry; R A Clark
Journal:  BMC Health Serv Res       Date:  2022-02-28       Impact factor: 2.908

7.  Implementation and prospective evaluation of the Country Heart Attack Prevention model of care to improve attendance and completion of cardiac rehabilitation for patients with cardiovascular diseases living in rural Australia: a study protocol.

Authors:  Alline Beleigoli; Stephen J Nicholls; Alex Brown; Derek P Chew; John Beltrame; Anthony Maeder; Carol Maher; Vincent L Versace; Jeroen M Hendriks; Philip Tideman; Billingsley Kaambwa; Christopher Zeitz; Ivanka J Prichard; Rosanna Tavella; Rosy Tirimacco; Wendy Keech; Carolyn Astley; Kay Govin; Katie Nesbitt; Huiyun Du; Stephanie Champion; Maria Alejandra Pinero de Plaza; Imelda Lynch; Vanessa Poulsen; Marie Ludlow; Ken Wanguhu; Hendrika Meyer; Ali Krollig; Lemlem Gebremichael; Chloe Green; Robyn A Clark
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 3.006

8.  The Impact of the SARS-CoV-2 Virus (COVID-19) Pandemic and the Rapid Adoption of Telehealth for Cardiac Rehabilitation and Secondary Prevention Programs in Rural and Remote Australia: A Multi-Method Study.

Authors:  Stephanie Champion; Robyn A Clark; Rosy Tirimacco; Philip Tideman; Lemlem Gebremichael; Alline Beleigoli
Journal:  Heart Lung Circ       Date:  2022-08-17       Impact factor: 2.838

9.  Reduction of the rate of hospitalization in patients with acute coronary syndrome: An action research.

Authors:  Safoura Dorri; Mansoureh Ashghali Farahani; Hossein Mohammadebrahimi; Saied Shahraki; Hamideh Hakimi
Journal:  Iran J Nurs Midwifery Res       Date:  2021-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.